Introduction
Porcine reproductive and respiratory syndrome (PRRS) was first reported in America in 1987 (Keffaber et al., 1992) , although evidence of an earlier presence has been described, both in the USA (Hill et al., 1992) and in south-east Asia (Shin et al., 1993) . PRRS has also recently been confirmed to have been present in Japan since 1989 (Shimizu et al., 1994) , where it is known as Heko-Heko. The disease was first confirmed in Britain in the spring of 1991 (Paton et al., 1991) at about the same time as the specific viral aetiology of the disease was established . In the next 18 months the virus, now shown to be an arterivirus (Meulenberg et al., 1993) , spread to several regions in Britain where it caused a very varied spectrum of disease . The first British virus isolate was obtained in June 1991 , since when a number of isolates have been made from separate field * Author for correspondence. Fax +44 1932 347046. cases in different parts of Britain. The genome of the virus contains eight open reading frames (ORFs), six of which are expressed by a nested set of subgenomic RNAs. O RF 1 a and O RF l b code for putative replication proteins, and the other six ORFs encode small polypeptides of between 128 and 265 amino acids (Meulenberg et al., 1993; Conzelmann et al., 1993) .
A number of serological studies have revealed strain differences among isolates, most markedly between those from the USA and Europe (Wensvoort et al., 1992; Bautista et al., 1993) , an observation that has correlated with subsequent revelations of significant differences in the genome of European and American isolates (Murtaugh, 1993 ). Lesser differences have been shown among isolates from Spain (Suarez et al., 1994) .
This report describes the preparation of monoclonal antibodies (MAbs) to a British PRRS virus (PRRSV), their characterization in terms of protein specificity by radioimmunoprecipitation (RIP) and Western blotting studies of their reactivity with infected cell lysates and in vitro translated products, and their ability to reveal antigenic variability among virus isolates from the UK, continental Europe and the USA.
Methods
Virus isolation. In vitro cultures of porcine alveolar macrophages (PAMs), prepared by the method of Wensvoort et al. (1991) , were used for virus isolation and culture work. UK viruses were isolated from individual sera, usually collected from acutely ill pigs. Virus isolation was confirmed by indirect peroxidase staining (immunoperoxidase monolayer assay; IPMA), using a PRRSV-specific polyclonal antiserum produced in a gnotobiotic pig (PCAS 5/91), rabbit anti-swine Ig conjugated to horseradish peroxidase (HRPO) (Dakopatts) and the chromagen 3-amino-9-ethyl carbazole (AEC). Foreign virus isolates were supplied as seed virus stocks by Dr Gert Wensvoort, Dr Sagar Goyal and Dr James Pearson.
MAb production. Three 180 cm * tissue culture flasks were seeded with PAMs at a density of 2 x 104 cells/m 2. After 3 h, they were infected with the H2 (Humberside, UK) isolate of PRRSV at an m.o.i, of 0.1. The cultures were incubated for 2 days at 37 °C, after which the superuatant was centrifuged at 10000g for 30 min to remove cell debris, passed through a 22 pm syringe-end filter and then ultracentrifuged at 132000g for 2h. The pellet was resuspended in 3-2ml 0.01 M-PBS pH 7.6. This virion concentrate, determined to have a titre of 1075TCIDs0/ml, was inactivated (virus inactivation was required because the disease was, at the time, subject to statutory controls in the UK) by treatment with 0-01 M-binary ethylenimine for 4 h at 37 °C, followed by addition of sodium thiosulphate to 2 % for 1 h at room temperature. A previous attempt to inactivate the virus with a 2 × 10 -a dilution of fl-propiolactone at 4 °C overnight and at 37 °C for 1 h had failed.
The inactivated virus, in 0-1 ml to 0-5 ml vols, was inoculated intraperitoneally into BALBC mice at weekly intervals on up to five occasions and the mice were killed at 28-57 days post-inoculation. Spleen cells were hybridized with NS 1 myeloma cells, as described by Edwards et al. (1988) . Hybridomas secreting virus-specific antibodies were selected by an IPMA modified to detect mouse antibodies binding to the homologous H2 isolate of PRRSV. Six MAbs were identified, cloned three times by limiting dilution and designated WBE1-6. For the studies described herein, MAbs were prepared as 10 × concentrates from hybridoma supernatants, purified by ammonium sulphate precipitation.
Protein specificities. The protein specificities of the MAbs were initially assessed by RIP using PAM lysates infected with the H2 strain of PRRSV. Though WBE1, 4, 5 and 6 precipitated proteins (data not shown), difficulties were encountered in determining the specificity of the other MAbs, so the CL2621 cell line and Lelystad virus (LV) were substituted. The virus was used at an m.o.i, of 1, and after 24 h incubation, cultures were radiolabelled with 25 pCi/ml L-[~SS]methionine (Amersham), 8 h prior to lysis. Extraction involved treatment with 1% Triton X-100, 0'5% sodium deoxycholate, 0.1% SDS and 1 mMphenylmethylsulphonyl fluoride in PBS (PBS-TDS).
Clarified lysates derived from infected and control cells were incubated overnight at 4 °C with polyclonal antiserum (PCAS) 21 (Meulenberg et al., 1995) or MAb. The antibody-protein complexes were then precipitated with Protein-A-Sepharose CL-4B (Pharmacia), for 2 h at 4 °C, followed by pelleting and resuspending four times in PBS-TDS. Pelleted complexes were dissociated by boiling in a sample buffer containing 5 % 2-mercaptoethanol and separated by SDS-PAGE, using a 5% stacking gel above a 15% separating gel. Radiolabelled molecular mass markers in the range 14.3 kDa to 200 kDa were obtained from Amersham. After electrophoresis, gels were fixed and dried before autoradiography using Hyperfilm r-Max (Amersham).
Western blotting. This technique was carried out both on cell lysates prepared from H2-infected and control alveolar macrophages subjected to treatment with n-octyl fl-D-glucopyranoside (OGP), and on preparations of LV prepared by gradient centrifugation. LV was purified from CL2621 tissue culture supernatant firstly by centrifugation at 1500 r.p.m, to remove any cell debris. The supernatant, which had atitre of /> 108TCIDs0/ml, was then centrifuged at 19000 r.p.m, for 13 h at 4 °C. The resultant pellet was resuspended in 0-05 M-potassium phosphate and 0.14 M-NaC1, pH 7.0 and applied to a 20-50 % sucrose gradient and centrifuged at 4 °C for 16 h at an average r.c.f, of 136000g (32000 r.p.m, in a Beckman SW40Ti). The gradient was harvested in fractions, and dilutions were prepared, using 0'01 Msodium carbonate buffer, pH 9"5. These dilutions were then used to coat an ELISA microplate and the degree of viral protein content and infectious virus was determined by a subsequent ELISA and IPMA, using polyclonal antiserum and rabbit anti-pig Ig labelled with HRPO (Dakopatts). The fraction giving the highest reading in ELISA was diluted in phosphate buffer and centrifuged for 12 h at 136000 g and the pellet was resuspended in 500 ~tl phosphate buffer.
Virus protein samples, derived from cell lysates and from sucrose gradient purification, were diluted in Laemmli sample buffer (Laemmli, 1970) and separated on gels containing 12% acrylamide, using SDS-PAGE. Rainbow molecular mass markers in the range 14'3 kDa to 200 kDa were obtained from Amersbam. The separated proteins were electroblotted, in the case of cell lysate proteins, onto nylon membranes by semi-dry transfer (Sambrook et al., 1989) and in the case of sucrose gradient-purified samples, onto nitrocellulose membranes by standard electroblotting (Towbin et al., 1979) . Strips were incubated with dilutions of the MAbs, and incubated for 1 h at room temperature or 37 °C. After three washes in PBS containing 2 % NaC1 and 0.5 % Tween 80, the strips were incubated with rabbit anti-swine Ig-HRPO or rabbit anti-mouse Ig-HRPO for 1 h at room temperature or 37 °C. The strips were once more washed three times in PBS and either immersed in a solution of 0'3 M-AEC, 5'8 % (v/v) N,N-dimethylformamide, 0.05 M-sodium acetate buffer, pH 5 or 4-chloro-l-naphthol in 20 % (v/v) methanol, both with 0.5 pl/ml 30 % H202.
In vitro translation. In order to establish the origin of the proteins identified by RIP, in vitro translation products of the Netherlands reference strain (LV) of PRRSV were examined for reactivity with the MAbs. Individual ORFs were amphfied in a PCR using upstream and downstream oligonucleotide primers (5' CACGCCAGGTACCAGG-CCCA 3' and 5' AAAGCATCTGCAGGTCCGCG 3' for ORF3; 5' GGCAATTGGATCCATTTGGA 3' and 5' AGAAGCAAGCT_TT-GCGGAGTC 3' for ORF4; and 5' GGTTAACCTCGTCGACTA-TG3' and 5" CCTGATTAAGCTTGACCCCC 3" for ORF7) as described by Meulenberg et al. (1995) . The underlined nucleotides are mutated with respect to the genome sequence of LV (Meulenberg et al., 1993) , in order to create restriction sites within the primers.
The PCR products of ORFs 3, 4 and 7 were cloned into plasmid pGEM-4Z (Promega) and RNA transcripts were synthesized in vitro using SP6 RNA polymerase (Promega) as described by the manufacturer. RNAs were translated in a nuclease-treated rabbit reticulocyte lysate, both alone and in the presence of canine pancreatic microsomal membranes, to investigate glycosylation. MAbs WBE1-6 were then assayed for their ability to precipitate the resultant expression products by RIP.
Reactivity with detergent-treated antigen. Infected and control PAMs were treated with 2 % OGP and the protein extracts were diluted in 0.5 M-carbonate buffer pH 9"6 and coated onto polypropylene ELISA plates (Falcon 3712). Dilutions of the MAbs were then applied, and specific binding was assessed using a rabbit anti-mouse Ig-HRPO conjugate and H202 with chromagen tetramethyl benzidine.
Reactivity with PRRSV isolates in 1PMA. After two to three culture passages in PAMs, 18 UK field isolates, seven continental European isolates and eight USA isolates were grown in PAMs for 48 h and assessed for recognition by all six UK MAbs and the US MAb SDOW17 using IPMA. The LV strain of PRRSV was included in this study.
MAb competition. Biotinylation of the four UK MAbs and SDOW17
was carried out, essentially by the method of Bayer & Wilchek (1980) , using n-hydroxysuccinimide biotin (Sigma). By this method, WBE4, WBE5, WBE6 and SDOW17 were successfully labelled, retaining binding activity, but WBE1, WBE2 and WBE3 were not. Competitive assays were made using these reagents in IPMA, using the UK isolate H2, to detect blocking of the binding of the biotinylated signal MAbs by homologous and heterologous native MAb. Firstly, signal MAbs were titrated in doubling dilutions and the end-point determined by loss of staining. Thus, for each signal MAb, a dilution was determined that was two dilution steps back from the end-point dilution for that MAb, Competition was then detected by first applying doubling dilutions of native MAb, incubating at 37 °C for 1 h, washing and then applying the pre-determined dilution of signal MAb. After a further incubation step, binding of the signal MAb was detected by the use of streptavidin-blOtln-HRPO (Amersham) and AEC. Cultures were examined under the microscope for presence or absence of specific staining of PRRSV-infected cells.
Results

Protein specificities of the M A b s
To obtain M A b s specific for P R R S V , mice were immunized with inactivated virus as described in W B E 5 and W B E 6 strongly precipitated a protein with a n a p p a r e n t m o l e c u l a r mass o f 15 k D a (N), and s o m e w h a t less strongly precipitated a second protein o f 14 k D a (Fig. 1 ). These two bands were also visualized after precipitation with P C A S 21. In addition, a n u m b e r o f other bands were precipitated using this serum, including strong bands at a p p a r e n t molecular masses of 18 k D a (M), 2 5 k D a (E) and 4 5 k D a (Fig. 1) . The 25 k D a protein has been shown to be the m a j o r envelope glycoprotein E expressed by O R F 5 , and the 18 k D a protein represents the unglycosylated m e m b r a n e protein M, expressed by O R F 6 (Meulenberg et al., 1995) . The sizes o f these proteins are similar to those reported for the putative nucleocapsid, m e m b r a n e and envelope proteins of other arteriviruses (Zeegers et al., 1976; 3 . In vitro translation products of ORF7, produced using the rabbit reticulocyte system, and radioimmunoprecipitated with MAbs WBE1-6, corresponding to lanes 1-6. Lane 7 shows the unprecipitated ORF7 product. Berlo et al., 1983; Ishitawa & Harawasa, 1987; de Vries et al., 1992) . The same 15 kDa N protein was detected by Western blot analysis of cell lysates with WBE1, 4, 5 and 6 (data not shown) and in purified LV (Fig. 2 ) using WBE4. A Western blot of purified virion fraction using PCAS 21 revealed, besides the presence of the 15 kDa N protein, the presence of two other viral proteins E and M, with apparent molecular masses of 25 kDa and 18 kDa (Fig.  2) .
In order to further define the MAb specificity, their reactivity was studied in RIP of in vitro products of the individual ORFs of LV, produced as described in the previous section. The product of in vitro translation of ORF7 resulted in a major band of 15 kDa and a minor band of 14 kDa, which were immunoprecipitated by MAbs WBE1 and WBE4-6 (Fig. 3) . This indicated that these MAbs are specific for the protein encoded by ORF7, most likely the nucleocapsid protein because of predicted size and sequence similarity with the nucleocapsid protein of lactate dehydrogenase elevating virus (LDV) and equine arteritis virus (EAV) (Meulenberg et al., 1993) . The in vivo and in vitro translation and coprecipitation of a smaller, 14 kDa band with the major 15 kDa product of ORF7 is probably due to the presence of a minor product formed either as a result of proteolytic degradation, premature translational stop or internal initiation of translation. In the sequences of LV and another virus from the Netherlands, isolate 10 ( Conzelmann et al., 1993) , there exist four in-frame methionine codons within ORF7, at nucleotide positions 48, 96 and 315, that could result in internal initiation.
MAb WBE2 was shown to precipitate a protein with an apparent molecular mass of 45 kDa in analysis by RIP (Fig. 1) , using a lysate prepared from LV-infected CL2621 cells. We were not able to obtain any specific results with WBE2 in Western blots using lysates of H2-infected PAM cells (data not shown) but when sucrose gradient-purified LV was used, WBE2 detected the presence of a protein of an apparent molecular mass of 47 kDa (Fig. 2) . A study of the reactivity of WBE2 with the in vitro translation products of ORF3 in the absence and presence of microsomal membranes, to investigate glycosylation, revealed that it bound to proteins of 29 kDa and 45 kDa respectively (Fig. 4) . The size of this latter protein correlated with the findings of the RIP study. Control RIPs were also performed, using the in vitro translation product of ORF4 and MAb WBE4, with no immunoprecipitation being observed. WBE3 failed to precipitate any proteins from lysates of cells infected with the parental strain, H2. As this MAb did not bind to PAMs infected with the Lelystad isolate of PRRSV, it was not expected to show any reactivity with lysates of CL2621 cells infected with that virus (Fig. 2, lane 2) . The reactivity of this MAb with the in vitro translation products of the ORFs of the Lelystad isolate were not investigated.
The measure of binding of MAbs to OGP-treated cell lysates from infected macrophage cultures showed that, whereas all of the MAbs recognized the H2 isolate in IPMA, only WBE4, WBE5 and WBE6 bound strongly to ELBA plates coated with OGP-extracted antigen prepared from this virus. WBE 1 bound very weakly only at high concentration, and the binding of WBE2 and WBE3 was completely lost. all UK isolates, whilst WBE2 and WBE3 reacted with only some isolates ( Table 1 ). The epitope recognized by WBE2 was found in all isolates obtained from the area of the original outbreak in the UK before March 1992 and intermittently thereafter. MAb WBE3 stained all cells infected with the parental H2 virus, but stained only a small proportion of cells infected with isolates NY1 (one of the first outbreaks), H5 and NY2. These cultures were confirmed as fully infected by subsequent staining with MAb WBE6. All four of these isolates were obtained from cases occurring in the adjoining districts of Humberside and North Yorkshire in the first months of the outbreak in the UK. Staining with WBE2 and WBE3, and to some extent, WBE1, was observed to be variable in intensity and granular, with distinct foci of viral antigen seen within the cytoplasm of infected cells (Fig. 5) . The US MAb, SDOW17, specific for the 15 kDa protein (Benfield et al., 1992) , recognized all isolates.
(ii) Continental European isolates. The staining pattern with continental European isolates was similar to that seen with UK isolates, with WBE1 and WBE4-6 recognizing all isolates ( Table 2 ). The epitope recognized by WBE2, shown here to be the product of ORF3, is present in the Lelystad virus, isolated in early 1991, and is variably present in the other continental European viruses tested, which have been isolated since that time, giving a picture similar to that seen for UK isolates. The epitope recognized by MAb WBE3 has not been detected in any continental European isolate so far tested.
(iii) US isolates. No UK MAb reacted with any of the US isolates tested (Table 2 ). All these isolates reacted with UK PCAS 5/91 and with a US MAb, SDOW17, though the staining with the former was somewhat weaker than that seen with UK and continental European isolates.
MAb competition
In order to study the competition between different MAbs, the MAbs were biotinylated and used in IPMA. In the IPMA test, an assay was made of the binding of biotinylated signal MAbs to macrophages previously treated with dilutions of native MAb. This revealed that binding of signal MAbs WBE4, WBE5 and WBE6 was strongly blocked by both homologous and heterologous native MAb, over two to three 10-fold dilutions, suggesting that they recognize a similar or proximal epitope. Only homologous blocking was seen with SDOW17 suggesting its epitope was a different one. WBE1, 2 and 3 were adversely affected by biotinylation and subsequently failed to bind to PRRS-infected PAMs, so were not used as signal MAbs. Nevertheless, as native MAbs they showed no ability to block the binding of signal MAbs WBE4, 5 and 6, or SDOW17 (Table 3) .
Discussion
The findings presented here demonstrate the variability of certain PRRSV proteins and show that MAbs can be produced against at least two different proteins of the virus. Four of the MAbs we produced are directed towards a 15 kDa protein that is translated from ORF7 and probably represents the virus nucleocapsid. The studies of virus specificity indicate that certain epitopes on the putative nucleocapsid are conserved among UK and continental PRRSV isolates, but are not shared with the US isolates studied. This complements the findings of Nelson et al. (1993) , who described the reactivity of three nucleocapsid-specific MAbs derived from two US viruses, one MAb recognizing all European and US isolates tested, and the other two only recognizing US isolates.
Competitive binding studies using native and biotinylated nucleocapsid-specific MAbs WBE4, 5 and 6 revealed that each of these MAbs blocked binding of the other two in IPMA. This reciprocal competition of binding suggests that WBE4, 5 and 6 recognize epitopes on the same antigenic domain that are identical or spatially close. Their lack of competition with US MAb SDOW17 indicates that their epitope is different to that recognized by the US MAb, shown to be also on the putative nucleocapsid protein N (Benfield et al., 1992) . Though our failure to biotinylate WBE1 limits our data on its ability to compete, our results suggest that it recognizes an epitope on the N protein different to that recognized by the other MAbs in the study and that is also absent on US isolates.
The MAb WBE2 appears to be directed at an epitope on a protein with an apparent molecular mass of 45 kDa and encoded by ORF3, as evidenced by the in vitro translation study presented here. The function of this protein is unknown. Meulenberg et al. (1993) describe it as comprising 265 amino acids, with seven sites of potential glycosylation. Following transciption of ORF3 in the absence of microsomal membranes, WBE2 precipitated a protein with a molecular mass of 29 kDa, suggesting that the protein is glycosylated during translation in vitro, with a size difference approximating 18 kDa between glycosylated and unglycosylated peptides. One glycosyl moiety has a molecular mass of approximately 2-3 kDa (Trimble et al., 1983) , consistent with between six and nine sites on the ORF3 protein being glycosylated in vitro. The binding of WBE2 to a 45 kDa protein in RIP and a 47 kDa protein in Western blot analysis indicates that a comparable degree of glycosylation may occur during in vivo translation. The small difference in apparent molecular mass of this protein when detected by RIP compared to Western blotting may be due to differences in the percentage of acrylamide used in the experiments, or might reflect a small difference in the degree of glycosylation of the protein predominating in cell lysate, compared to that present in the virion. The size of the unglycosylated protein closely matches the prediction of 30"6 kDa made by Meulenberg et al. (1993) from the sequence of the Lelystad isolate of PRRSV. Sequence analysis of the protein indicates that the ORF3 product contains a putative N-terminal signal sequence. However, it does not contain a C-terminal hydrophobic region which may be involved in membrane anchoring, as is the case for typical Class I membrane proteins. Our ability to induce an immune response to this protein in mice, using an inoculum prepared by centrifugation of a fltered tissue culture supernate, suggests that it is likely to be a protein associated with the excreted virus. Our Western blotting experiments show that this protein is also present in sucrose gradient-purified material, further indicating that it is physically associated with the virion. The topology of the protein is still unknown. In another arterivirus, EAV, ORF3 codes for a smaller protein than that coded by PRRSV, but its role for this virus has not been determined. An anti-virion serum, prepared in rabbits, only immuno-precipitated products of ORFs 2, 5, 6 and 7 (de Vries et al., 1992) , endorsing their role as structural proteins.
The observation that WBE2 successfully bound to the ORF3 translated product in its unglycosylated form, demonstrates that glycosylation is not required for recognition of this epitope. Binding was destroyed when the virus extract was treated with the detergent OGP, indicating that the epitope is probably not linear and therefore likely to be conformation-dependent. It is most likely that this epitope is formed by the secondary structure of the ORF3 product, as subsequent tertiary folding and hetero-or homo-oligomerization usually only occur as a consequence of, or after, glycosylation (Doms et al., 1993) . This epitope was not destroyed by the rather more gentle detergent treatment to which the protein was subjected during the technique of RIP. The binding of WBE3 with all cells infected with the parental isolate of PRRS, H2, and a very small proportion of the cells infected with three other isolates from the northeast of the UK, suggests the presence of an epitope on this protein that is highly variable.
The reactivity studies with the panel of MAbs revealed that antigenic variation exists both between and within PRRSV isolates. Serological evidence of antigenic variation with this virus has previously been reported Edwards et al., 1992; Wensvoort et al., 1992) . Our MAbs WBE1 and WBE4-6 confirmed that common epitopes on this protein do exist among UK and continental European isolates, but that these were not present in PRRS viruses from the USA so far studied. The variable reactivity of WBE2 and WBE3 among European isolates has, in addition, demonstrated that certain epitopes on other viral proteins may be more variable. A comparison of the proteins encoded by the genomes of the US isolate VR-2332 and Lelystad virus by Murtaugh (1993) , show numerous differences in molecular mass, isoelectric point and predicted glycosylation sites, with ORF3 of VR-2332 having 60% amino acid identity with Lelystad virus and ORF7 having 64% identity, using the Needleman-Wunsch algorithm. A study of US isolate VR2385 (Meng et al., 1994) and Qudbec isolate IAF-exp91 (Mardassi et al., 1994) , revealed the ORF7 product of both these American viruses to be 123 amino acids long, compared to 128 amino acids for the European isolates LV (Meulenberg et al., 1993) , and Isolate 10 (Conzelmann et al., 1993) , with 63% amino acid identity and large continuous areas of consensus.
Antigenic variation has been shown using three US MAbs to PRRS viruses (Nelson et al., 1993) and in two other arteriviruses, EAV and LDV of mice. With EAV, variation has been detected within an outbreak, between virus isolates from the same carrier stallion over an extended period and also among isolates worldwide (Murphy et al., 1992) . The genomic variability of LDV has also been described in reviews by Rowson & Mahy (1985) , and Plagemann & Moennig (1992) . High mutation rates are a feature of RNA viruses (Holland et al., 1982) , and can lead to the establishment of heterologous populations, described as quasispecies (Domingo et al., 1985) . It is not surprising that this type of variation should be found in PRRSV, a virus which has been shown to cause relatively persistent infections, with concurrent viraemia and virus-specific antibody. Such co-existence could promote the proliferation of variant strains in vivo, perhaps of varying pathogenicity, which may be favoured by these and other selective pressures. Control strategies involving vaccination should therefore take such variation into account.
